Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Outskill Genai
    HomeNewsBusinessCompaniesSun Pharma's Halol unit: Observations are minor & could be remedied easily, says Nirmal Bang

    Sun Pharma's Halol unit: Observations are minor & could be remedied easily, says Nirmal Bang

    In an interview with CNBC-TV18, Vishal Manchanda of Nirmal Bang Institutional Equities spoke about the observations and gave his views on the stock.

    CNBC-TV18
    March 06, 2018 / 11:57 IST

    CNBC-TV18 accessed form 483 issued to Sun Pharmaceutical's Halol facility where the US drug regulator has issued 3 observations.

    In an interview with CNBC-TV18, Vishal Manchanda of Nirmal Bang Institutional Equities spoke about the observations and gave his views on the stock.

    We got the observations reviewed by a consultant and the opinion is largely that these are minor, so they can get through in a shorter timeframe, he said.

    For full interview, watch accompanying video...

    CNBC-TV18
    first published: Mar 6, 2018 10:10 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347